Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain

Benfield, C T O; MacKenzie, F; Ritzefeld, M; Mazzon, M; Weston, S; Tate, E; Teo, B H; Smith, S E; Kellam, P; Holmes, E C; Marsh, M

doi:10.26508/lsa.201900542

Research Repository

Advanced Search

Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain

Benfield, C T O; MacKenzie, F; Ritzefeld, M; Mazzon, M; Weston, S; Tate, E; Teo, B H; Smith, S E; Kellam, P; Holmes, E C; Marsh, M

Authors

C T O Benfield

F MacKenzie

M Ritzefeld

M Mazzon

S Weston

E Tate

B H Teo

S E Smith

P Kellam

E C Holmes

M Marsh

Citation

Benfield, C. T. O., MacKenzie, F., Ritzefeld, M., Mazzon, M., Weston, S., Tate, E., …Marsh, M. (2019). Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain. Life Science Alliance, 3(1), https://doi.org/10.26508/lsa.201900542

Journal Article Type	Article
Acceptance Date	Nov 28, 2019
Publication Date	Dec 11, 2019
Deposit Date	Dec 14, 2019
Publicly Available Date	Nov 20, 2020
Journal	Life Science Alliance
Publisher	Life Science Alliance
Peer Reviewed	Peer Reviewed
Volume	3
Issue	1
DOI	https://doi.org/10.26508/lsa.201900542
Public URL	https://rvc-repository.worktribe.com/output/1379385